Literature DB >> 32051672

The cost-effectiveness of antibiotic-loaded bone cement versus plain bone cement following total and partial knee and hip arthroplasty.

Tyler Hoskins1, Jay K Shah1,2, Jay Patel1, Chris Mazzei1, David Goyette1, Eileen Poletick1, Thomas Colella1, James Wittig1.   

Abstract

BACKGROUND: Postoperative infection is one of the most prevalent complications following total joint arthroplasty (TJA). As such procedures become more prevalent, it is imperative that we develop new prophylactic methods to prevent the need for revision procedures. In recent years, surgeons have opted to use antibiotic-loaded bone cement (ALBC) rather than plain bone cement (PBC) in primary hip and knee replacements due to its theoretical potential of lowering infection rates. However, the cost-effectiveness of this intervention remains in question.Questions/Purposes: To determine the rate of infection and cost-effectiveness of antibiotic-loaded bone cement as compared to plain bone cement in hip and knee arthroplasty. PATIENTS AND METHODS: We reviewed 4116 primary hip and knee arthroplasty cases performed between 2016 and 2018 at Morristown Medical Center in New Jersey. Data regarding demographics, complications, and any readmissions due to deep infection were collected retrospectively. During that time period there were a total of 4016 knee cases (423 ALBC, 3593 PBC) and 123 hip cases (63 ALBC, 60 PBC). The average cost for one bag of antibiotic-loaded bone cement and plain bone cement for hip and knee arthroplasty was $336.42 and $72.14, respectively. A statistical analysis was performed using Fisher's exact test; the National Healthcare Safety Network (NHSN) surgical site infection guidelines were used to distinguish between superficial and deep infections.
RESULTS: Ten patients were readmitted due to deep infection, all of whom had undergone total knee arthroplasty. Of those cases, plain bone cement was used for the index procedure in seven instances and antibiotic-loaded cement was used in three. This resulted in an infection rate of 0.19% and 0.62%, respectively, p = 0.103. There was no statistically significant difference in infection rates between the two groups. A total of 778 bags of ALBC were used in 423 knee surgeries, and 98 bags of ALBC were used in 63 hip cases. The total cost for ALBC in TKA and THA procedures was $261,734.76 (778*336.42) and $32,969.16 (98*336.42), respectively. If PBC had been used during all index procedures, it would have resulted in a total savings of $231,509.28.
CONCLUSIONS: Antibiotic-loaded cement did not significantly reduce the rate of infection for either knee or hip arthroplasty. Thus, the routine use of antibiotic-loaded cement in primary hip and knee arthroplasty may be an unnecessary financial burden to the healthcare system. A larger sample size and a randomized controlled trial would help confirm our findings and would provide further information on the cost-effectiveness of ALBC cement versus PBC.Significance/Clinical Relevance: In this review of cases performed from 2016 to 2018 there was no statistically significant difference between the rate of infection and the need for revision surgeries for patients treated with ALBC versus PBC. As hospital systems continue to transition towards a bundled payment model, it becomes imperative for providers to reduce any unnecessary costs in order to increase quality and efficiency. We estimate that our hospital system could save nearly $120,000/year by using plain bone cement instead of antibiotic-loaded cement. Published by Elsevier B.V. on behalf of Professor P K Surendran Memorial Education Foundation.

Entities:  

Keywords:  Cost-effectiveness; Hip; Infection; Joint arthroplasty; Knee

Year:  2020        PMID: 32051672      PMCID: PMC7005330          DOI: 10.1016/j.jor.2020.01.029

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  27 in total

1.  Mechanical properties of bone cements containing large doses of antibiotic powders.

Authors:  E P Lautenschlager; J J Jacobs; G W Marshall; P R Meyer
Journal:  J Biomed Mater Res       Date:  1976-11

Review 2.  Two-stage arthroplasty for prosthetic joint infection: a systematic review of acute kidney injury, systemic toxicity and infection control.

Authors:  Andrew Luu; Fahd Syed; Gowri Raman; Anshul Bhalla; Eavan Muldoon; Susan Hadley; Eric Smith; Madhumathi Rao
Journal:  J Arthroplasty       Date:  2013-04-08       Impact factor: 4.757

3.  The Economics of Antibiotic Cement in Total Knee Arthroplasty: Added Cost with No Reduction in Infection Rates.

Authors:  Michael Yayac; Alexander J Rondon; Timothy L Tan; Hannah Levy; Javad Parvizi; P Maxwell Courtney
Journal:  J Arthroplasty       Date:  2019-04-26       Impact factor: 4.757

4.  [Depot effects of various antibiotics mixed with Palacos resins].

Authors:  H W Buchholz; H Engelbrecht
Journal:  Chirurg       Date:  1970-11       Impact factor: 0.955

5.  Economic burden of periprosthetic joint infection in the United States.

Authors:  Steven M Kurtz; Edmund Lau; Heather Watson; Jordana K Schmier; Javad Parvizi
Journal:  J Arthroplasty       Date:  2012-05-02       Impact factor: 4.757

6.  Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty.

Authors:  Robert S Namba; Yuexin Chen; Elizabeth W Paxton; Tamara Slipchenko; Donald C Fithian
Journal:  J Arthroplasty       Date:  2009-07-04       Impact factor: 4.757

7.  Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register.

Authors:  Lars B Engesaeter; Stein Atle Lie; Birgitte Espehaug; Ove Furnes; Stein Emil Vollset; Leif Ivar Havelin
Journal:  Acta Orthop Scand       Date:  2003-12

8.  Acute renal failure after antibiotic-impregnated bone cement treatment of an infected total knee arthroplasty.

Authors:  S Dovas; V Liakopoulos; L Papatheodorou; I Chronopoulou; V Papavasiliou; E Atmatzidis; M Giannopoulou; T Eleftheriadis; T Simopoulou; T Karachalios; I Stefanidis
Journal:  Clin Nephrol       Date:  2008-03       Impact factor: 0.975

9.  Effectiveness of gentamicin-impregnated cement in the prevention of deep wound infection after primary total knee arthroplasty.

Authors:  Matthieu Eveillard; Patrice Mertl; Blaise Tramier; François Eb
Journal:  Infect Control Hosp Epidemiol       Date:  2003-10       Impact factor: 3.254

10.  Antibiotic bone cement's effect on infection rates in primary and revision total knee arthroplasties.

Authors:  Donald Kleppel; Jacob Stirton; Jiayong Liu; Nabil A Ebraheim
Journal:  World J Orthop       Date:  2017-12-18
View more
  3 in total

1.  Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial).

Authors:  Tesfaye H Leta; Jan-Erik Gjertsen; Håvard Dale; Geir Hallan; Stein Håkon Låstad Lygre; Anne Marie Fenstad; Gro Sævik Dyrhovden; Marianne Westberg; Tina Stromdal Wik; Rune Bruhn Jakobsen; Arild Aamodt; Stephan Maximillian Röhrl; Øystein Johannes Gøthesen; Einar Lindalen; Stig Heir; Jarle Ludvigsen; Trond Bruun; Ann Kristin Hansen; Knut Erik Moen Aune; Marianne Warholm; John Petter Skjetne; Mona Badawy; Pål Høvding; Otto Schnell Husby; Øystein Espeland Karlsen; Ove Furnes
Journal:  BMJ Open       Date:  2021-01-28       Impact factor: 2.692

2.  The Effect of TBB, as an Initiator, on the Biological Compatibility of PMMA/MMA Bone Cement.

Authors:  Kosuke Hamajima; Ryotaro Ozawa; Juri Saruta; Makiko Saita; Hiroaki Kitajima; Samira Rahim Taleghani; Dan Usami; Donya Goharian; Mitsunori Uno; Ken Miyazawa; Shigemi Goto; Keiichi Tsukinoki; Takahiro Ogawa
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

3.  Application and Clinical Effectiveness of Antibiotic-Loaded Bone Cement to Promote Soft Tissue Granulation in the Treatment of Neuropathic Diabetic Foot Ulcers Complicated by Osteomyelitis: A Randomized Controlled Trial.

Authors:  Regis Ernest Mendame Ehya; Hao Zhang; Baiwen Qi; Aixi Yu
Journal:  J Diabetes Res       Date:  2021-07-13       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.